Plain-English translation of NCT04318366 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are building a large database and sample collection from people with COVID-19 to better understand why some patients become more seriously ill than others and how to predict which treatments will help each person. By studying blood samples, medical records, and imaging results from 6,000 patients, the team hopes to discover which patients need the most urgent care and which specific treatments might benefit different groups.
During the COVID-19 pandemic, doctors realized that patients respond very differently to infection — some recover quickly while others become critically ill. This research aims to find early warning signs and predictors so doctors can give the right treatment to the right patient at the right time.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would have blood samples and other biological samples collected as part of your hospital care or emergency department visit. Researchers would also review your medical records, imaging scans, and basic information about you (age, medical history, symptoms) to add to their database. The study does not involve taking any new medication — it simply collects information and samples that help doctors learn how to better care for COVID-19 patients in the future.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
Italy